Establishment Labs Holdings Inc (FRA:3E0)
€ 43.2 0 (0%) Market Cap: 1.20 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 41.09 GF Score: 78/100

Establishment Labs Holdings Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 06:30PM GMT
Release Date Price: €52
Caroline Borowski;JPMorgan Securities LLC.;Analyst

Good afternoon, and thank you for joining us today at the JPMorgan Healthcare Conference. My name is Caroline Borowski, and I'm a team member here at the JPMorgan coverage team. Today, we are pleased to welcome Establishment Labs. Before I introduce you to our presenters, I want to draw your attention to the Blue Button at the bottom of your screen. That is where you can submit questions that we can go through it in the later part of this session during the Q&A. With that, I will turn it over to Juan Jose, CEO of Establishment Labs.

Juan Jose Chacon Quiros
Establishment Labs Holdings Inc. - Founder, CEO & Executive Director

Thank you, Caroline, and welcome, everyone. I am the Founder and Chief Executive Officer of Establishment Labs. And I want to tell you today about our story of innovation as a women's health company in breast aesthetics for reconstruction. So as a company dedicated to this field, we are in the medical device space. But what we have been doing very much to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot